<p>SYNERGY announced that the company's raw material drug Mesalazine Potassium has passed the drug GMP compliance inspection, which is beneficial for the company to expand the product's sales in the domestic market, forming a good pattern of simultaneous sales in both domestic and foreign markets. Mesalazine Potassium is suitable for the treatment of adult primary hypertension</p>

300636

<p>SYNERGY announced that its raw material drug, Mesalazine Potassium, has passed the GMP compliance inspection, which is beneficial for the company to expand the sales of its products in the domestic market, forming a good pattern of simultaneous sales in both domestic and foreign markets. Mesalazine Potassium is suitable for the treatment of adult primary hypertension</p>

SYNERGY: The raw material drug Amlodipine Besylate has passed the GMP compliance inspection